Skip to content
Skip to navigation
Skip to footer

Archive

View global media contacts

Home / Media Centre / Archive

Here you can find the archive of all Press Releases prior to 2022

Filter by date:

Showing 1107 press releases before 2022

US FDA approves Imfinzi for unresectable Stage III non-small cell lung cancer
19 February 2018
Selumetinib granted Orphan Drug Designation by the US FDA for neurofibromatosis type 1
15 February 2018
Brilinta significantly reduces CV events and coronary death beyond one year in heart attack survivors with multi-vessel disease
7 February 2018
Full-Year 2017 Results
2 February 2018
AstraZeneca reports top-line Phase III KRONOS trial results for PT010 triple combination therapy in chronic obstructive pulmonary disease
26 January 2018
AstraZeneca listed as one of the world’s top-100 most sustainable companies and recognised for its three-fold increase in renewable energy usage
23 January 2018
Lynparza receives approval in Japan for the treatment of advanced ovarian cancer
19 January 2018
Fasenra receives approval in Japan
19 January 2018
Lynparza approved by US FDA in germline BRCA-mutated metastatic breast cancer
12 January 2018
AstraZeneca receives EU approval of Fasenra for severe eosinophilic asthma
10 January 2018

<
1
2
3
111
>

All of our latest press releases and articles are available to explore